Who owns CARISMA THERAPEUTICS INC?
- Ticker: CARM
- CUSIP Number: 14216r101
Tip: Access positions for across all investors
Analyze quarterly positions in Carisma Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Carisma Therapeutics stock
Who bought or sold CARISMA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.4M | $2.2M | -8% | Jun 2024 |
|
| BlackRock | 710k | $1.1M | -59% | Jun 2024 |
|
| Tpg Gp A | 561k | $551k | -33% | Sep 2024 |
|
| Barclays | 549k | $539k | 3661933% | Sep 2024 |
|
| BlackRock | 409k | $401k | 100% | Sep 2024 |
|
| Geode Capital Management | 259k | $255k | -9% | Sep 2024 |
|
| Goldman Sachs Group | 233k | $354k | 100% | Jun 2024 |
|
| Renaissance Technologies | 207k | $203k | 48% | Sep 2024 |
|
| State Street Corporation | 85k | $129k | -84% | Jun 2024 |
|
| Northern Trust | 76k | $74k | -66% | Sep 2024 |
|
| Wexford Capital | 35k | $34k | 100% | Sep 2024 |
|
| Qube Research & Technologies | 32k | $48k | 100% | Jun 2024 |
|
| Empowered Funds | 30k | $30k | 5% | Sep 2024 |
|
| Bridgeway Capital Management | 29k | $44k | -87% | Jun 2024 |
|
| Blodgett Wealth Advisors | 25k | $25k | -2% | Sep 2024 |
|
| Morgan Stanley | 22k | $33k | -47% | Jun 2024 |
|
| Tower Research Capital | 16k | $25k | 56% | Jun 2024 |
|
| Stratos Wealth Partners | 12k | $12k | 0% | Sep 2024 |
|
| Bank of America Corporation | 7.3k | $7.1k | -83% | Sep 2024 |
|
| Federated Investors | 5.0k | $4.9k | 50% | Sep 2024 |
|
| Group One Trading | 2.2k | $2.2k | 0% | Sep 2024 |
|
| Macquarie Group | 1.4k | $2.1k | 100% | Jun 2024 |
|
| Jpmorgan Chase & Co | 921.00 | $903.961500 | 0% | Sep 2024 |
|
| Russell Investments | 645.00 | $980.013000 | 100% | Jun 2024 |
|
| Bank & Trust | 525.00 | $515.025000 | 0% | Sep 2024 |
|
| Capital Performance Advisors | 500.00 | $491.000000 | 100% | Sep 2024 |
|
| Peoples Bank | 250.00 | $245.000000 | 0% | Sep 2024 |
|
| IFP Advisors | 206.00 | $312.996400 | 0% | Jun 2024 |
|
| ORG Partners | 200.00 | $196.000000 | 0% | Sep 2024 |
|
| National Bank Of Canada /fi/ | 165.00 | $161.997000 | 230% | Sep 2024 |
|
| NISA Investment Advisors | 161.00 | $158.005400 | 705% | Sep 2024 |
|
| Advisor Group Holdings | 142.00 | $139.003800 | 0% | Sep 2024 |
|
| Harbour Investments | 37.00 | $36.001000 | 0% | Sep 2024 |
|
| Citigroup | 10.00 | $10.000000 | -100% | Sep 2024 |
|
| McMahon Financial Advisors | 8.00 | $8.000000 | 0% | Sep 2024 |
|
Who sold out of Carisma Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2024 | 160k | $243k |
| Jane Street | Jun 2024 | 160k | $243k |
| Nuveen Asset Management | Mar 2024 | 103k | $233k |
| Y-Intercept | Jun 2024 | 76k | $115k |
| Susquehanna International | Jun 2024 | 73k | $112k |
| Centiva Capital | Jun 2024 | 55k | $83k |
| Two Sigma Investments | Mar 2024 | 41k | $92k |
| Sunrise Partners Limited Partnership | Jun 2024 | 32k | $48k |
| Point72 Asia | Jun 2024 | 26k | $40k |
| Mirae Asset Global Etfs Holdings | Jun 2024 | 13k | $20k |
| Rhumbline Advisers | Jun 2024 | 8.4k | $13k |
| White Bay PT | Jun 2024 | 5.2k | $8.0k |
| Point72 | Jun 2024 | 2.0k | $3.0k |
| New York State Common Retirement Fund | Jun 2024 | 212.00 | $0 |
| Old Point Trust & Financial Services N A | Jun 2024 | 125.00 | $190.000000 |
| Royal Bank of Canada | Jun 2024 | 104.00 | $0 |
| CWM | Jun 2024 | 48.00 | $0 |
| Signature Resources Capital Management | Jun 2024 | 14.00 | $21.000000 |